Francesco Parlati

Francesco Parlati

Plus aucun poste en cours
57 ans
Health Technology
Consumer Services

Profil

Francesco Parlati was the founder of Cleave Therapeutics, Inc. (founded in 2010) where he held the title of Senior Director-Biology from 2010 to 2012.
He also worked at Proteolix, Inc. as an Associate Director-Biology from 2004 to 2009.
Prior to that, he was a Scientist at Rigel Pharmaceuticals, Inc. from 2001 to 2003.
Currently, Dr. Parlati is the Senior Vice President-Research at Calithera Biosciences, Inc. (2012-present).
Dr. Parlati obtained his doctorate degree from McGill University in 1996 and completed his undergraduate studies at Concordia University.

Anciens postes connus de Francesco Parlati

SociétésPosteFin
CALITHERA BIOSCIENCES, INC. Directeur Technique/Scientifique/R&D 01/01/2023
Fondateur 01/01/2012
Corporate Officer/Principal 01/10/2009
RIGEL PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 01/12/2003
Voir l'expérience en détail de Francesco Parlati

Formation de Francesco Parlati

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

70

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Francesco Parlati